Fundraising FoxQiming Venture Partners USA — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Healthcare
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).
BiotechHealthtechBerkeley, US
Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)Thomas Gustafson(Executive Officer)inEmily Conley(Executive Officer, Director)in
BoardEvan Caplan(Director)inCharlotte McKee(Director)
Co-investors5AM VenturesOrbiMedAtlas VentureQiming Venture Partners
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)in
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdMitsui Global InvestmentAlleyCorpArkin Digital HealthGaingels+3 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Ittai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMana VenturesMitsui Global Investment+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.